Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11327)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 6, 2017 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ramos H, Linares P, Badia E, Martín I, Gómez J, Almohalla C, Jorquera F, Calvo S, García I, Conde P, Álvarez B, Karpman G, Lorenzo S, Gozalo V, Vásquez M, Joao D, de Benito M, Ruiz L, Jiménez F, Sáez-Royuela F, Asociación Castellano y Leonesa de Hepatología (ACyLHE). Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting. World J Gastrointest Pharmacol Ther 2017; 8(2): 137-146 [PMID: 28533924 DOI: 10.4292/wjgpt.v8.i2.137] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5349/full/v8/i2/137.htm |
| Number | Citing Articles |
| 1 |
Kellie Young, Benny Liu, Taft Bhuket, Robert G. Gish, Robert J. Wong. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct‐acting antiviral therapies in the United States. Journal of Viral Hepatitis 2019; 26(3): 350 doi: 10.1111/jvh.13039
|
| 2 |
Jose Luis Calleja, Jaime Espin, Ankita Kaushik, Manuel Hernandez-Guerra, Rob Blissett, Alon Yehoshua, Adam Igloi-Nagy. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals. PharmacoEconomics - Open 2024; 8(2): 221 doi: 10.1007/s41669-023-00458-3
|
| 3 |
Rion Masaoka, Yoshinori Gyotoku, Ryosaku Shirahashi, Toshikuni Suda, Masaya Tamano. Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance. World Journal of Clinical Cases 2023; 11(22): 5198 doi: 10.12998/wjcc.v11.i22.5198
|
| 4 |
Maia Butsashvili, Lia Gvinjilia, George Kamkamidze, David Metreveli, Shorena Dvali, Tamar Rukhadze, Amiran Gamkrelidze, Muazzam Nasrullah, Shaun Shadaker, Juliette Morgan, Francisco Averhoff. High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia. BMC Research Notes 2020; 13(1) doi: 10.1186/s13104-020-05173-4
|
| 5 |
Hugo Perazzo, Marcelino Jose Jorge, Julio Castro Silva, Alexandre Monken Avellar, Patrícia Santos Silva, Carmen Romero, Valdilea Gonçalves Veloso, Ruben Mujica-Mota, Rob Anderson, Chris Hyde, Rodolfo Castro. Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0676-8
|
| 6 |
Romeo-Gabriel Mihăilă. Liver stiffness in chronic hepatitis C virus infection. Romanian Journal of Internal Medicine 2019; 57(2): 85 doi: 10.2478/rjim-2018-0034
|
| 7 |
Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239
|
| 8 |
Rafael Esteban, Raquel Domínguez-Hernández, Victoria Martín-Escudero, Miguel Ángel Casado, Matteo Ruggeri. Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain. PLOS ONE 2022; 17(12): e0278544 doi: 10.1371/journal.pone.0278544
|
| 9 |
Rion Masaoka, Yoshinori Gyotoku, Ryosaku Shirahashi, Toshikuni Suda, Masaya Tamano. Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance. World Journal of Clinical Cases 2023; 11(22): 5204-5214 doi: 10.12998/wjcc.v11.i22.5204
Abstract(606) |
Core Tip(373) |
Full Article(HTML)(1302)
|
Full Article with Cover (PDF)-1083K(128)
|
Full Article (Word)-299K(41)
|
Audio-1557K(10)
|
Peer-Review Report-293K(56)
|
Answering Reviewers-162K(57)
|
Full Article (PDF)-741K(140)
|
Full Article (XML)-127K(50)
|
Times Cited (1)
|
Total Visits (4981)
|
Open
|
| 10 |
Juan Turnes, Raquel Domínguez-Hernández, Miguel Ángel Casado. Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain. Gastroenterología y Hepatología (English Edition) 2017; 40(7): 433 doi: 10.1016/j.gastre.2017.07.008
|
| 11 |
Ulrich Spengler. Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection. Pharmacology & Therapeutics 2018; 183: 118 doi: 10.1016/j.pharmthera.2017.10.009
|
| 12 |
Yoshinori Gyotoku, Ryosaku Shirahashi, Toshikuni Suda, Masaya Tamano. Role of liver stiffness measurements in patients who develop hepatocellular carcinoma after clearance of the hepatitis C virus. Journal of Medical Ultrasonics 2022; 49(2): 253 doi: 10.1007/s10396-021-01188-x
|
| 13 |
Juan Turnes, Raquel Domínguez-Hernández, Miguel Ángel Casado. Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España. Gastroenterología y Hepatología 2017; 40(7): 433 doi: 10.1016/j.gastrohep.2017.05.004
|
| 14 |
Bryan Tolentino, Ritu R Singh, Suresh Misra, Douglas T Dieterich, Dost Sarpel. An Update On the Management of Hepatitis C Virus and Human Immunodeficiency Virus co-infection. Future Virology 2019; 14(3): 185 doi: 10.2217/fvl-2018-0116
|
| 15 |
I. A. Narkevich, E. A. Tsitlionok. Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2023; 16(4): 607 doi: 10.17749/2070-4909/farmakoekonomika.2023.193
|
| 16 |
Kellie Young, Benny Liu, Taft Bhuket, Robert J. Wong. Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals. Journal of Clinical and Experimental Hepatology 2020; 10(6): 581 doi: 10.1016/j.jceh.2020.02.003
|